Literature DB >> 21117349

Raynaud's phenomenon.

Renu Saigal1, Amit Kansal, Manoop Mittal, Yadvinder Singh, Hari Ram.   

Abstract

Raynauds phenomena (RP) is a commonly encountered clinical manifestation which may be primary or secondary to underlying disease. There is imbalance between vasoconstricting and vasodilating factors. Physical examination, nailfold capillaroscopy and immunological tests can differentiate primary from secondary RP. Treatment involves prevention of RP so that permanent ischemic damage i.e. gangrene can be avoided. Avoidance of exposure to cold, emotional stress and certain drugs is mandatory and if attacks are occurring then vasodilators, prostaglandin analogues, anticoagulants and antiplatelet drugs may be added. An attempt has been made to guide the clinician to diagnose and treat a patient of RP through this article.

Entities:  

Mesh:

Year:  2010        PMID: 21117349

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  5 in total

1.  Evaluation of test characteristics for outcome measures used in Raynaud's phenomenon clinical trials.

Authors:  Heather Gladue; Paul Maranian; Harold E Paulus; Dinesh Khanna
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-04       Impact factor: 4.794

2.  Severe digital necrosis in a 4-year-old boy: primary Raynaud's or jellyfish sting.

Authors:  Fatih Koksal Binnetoglu; Betul Kizildag; Naci Topaloglu; Ozgur Kasapcopur
Journal:  BMJ Case Rep       Date:  2013-11-18

3.  Post-traumatic Digital Gangrene Associated with Epinephrine Use in Primary Raynaud's Phenomenon: Lesson for the Future.

Authors:  Carlson-Babila Sama
Journal:  Ethiop J Health Sci       Date:  2016-07

4.  Nailfold Videocapillaroscopy in Connective Tissue Diseases with Raynaud's Phenomenon in an Indian Population.

Authors:  Sambit Sundaray; Siddhartha Mishra; Subhash Chandra Dash; Naba Kishore Sundaray
Journal:  Rambam Maimonides Med J       Date:  2022-01-27

5.  A serious case of primary Raynaud's phenomenon in an infant.

Authors:  Masaru Kobayashi; Ken-Ichi Takano; Junji Kamizono; Kotaro Ichikawa
Journal:  Clin Case Rep       Date:  2018-09-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.